IMMUNAWARE

immunAware is centered on advancing immunological studies, with an emphasis on high quality reagents and services. We can help with assessing potential T cell targets though our peptide-MHC binding analysis and the stability dynamics of peptide-MHC class I complexes, catering specifically to the needs of the pharmaceutical and biotechnological sectors... immunAware was created by scientists with a long standing experience within the field of MHC biochemistry and T cell immunology. We have developed peptide loadable MHC class I reagents and refined the production of custom pMHC complexes which comprises >100 distinct MHC class I and II molecules, including HLA-A, HLA-B, HLA-C, HLA-DR and H-2 variants... Spanning over three decades, our unwavering focus has centered on the intricate biochemistry of MHC class I and II molecules. We have harnessed this expertise to pioneer and refine methodologies to produce peptide-MHC class I and II monomers and tetramers including the creation of..

Also known as: immunAware ApS, immunAware INC

VAT numbers: 39189135

Primary location: Nashua United States